Xueli Bai

17PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiomedical imagingEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 02, 2026
Immunochemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer: A Randomized Controlled Trial.

|Aug 13, 2026
Chrysosplenetin-induced TMED3 aggregation triggers unfolded protein response in pancreatic cancer.

|Jul 30, 2026
Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma.

|Jul 10, 2026
Oncogenic EGFR rewires STING-TBK1 signalosomes to license DNA damage tolerance in NSCLC.

|Jun 24, 2026
Spatial immune atlas of breast cancer brain metastasis reveals CD163+ macrophage reprogramming associated with immune escape.

|Jun 18, 2026
SCP4 dephosphorylates mitotic histone H3 to maintain chromosome stability.

Pageof 3

Frequent Collaborators

5 joint publications

Xueli Bai

3 joint publications

Pinglong Xu

2 joint publications

Xiaobo Cai

2 joint publications

Wei Zhang